Vaccine for prevention and treatment of HIV-infection

Details for Australian Patent Application No. 2005268856 (hide)

Owner GlaxoSmithKline Biologicals sa

Inventors Marchand, Martine; Permanne, Philippe Jean Gervais Ghislain; Mathy, Nathalie Louise; Delchambre, Martine; Voss, Gerald Hermann; Abrecht, Helge

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005268856

PCT Pub. Number WO2006/013106

Priority 0417494.2 05.08.04 GB

Filing date 3 August 2005

Wipo publication date 9 February 2006

Acceptance publication date 24 May 2012

International Classifications

C07K 19/00 (2006.01) Hybrid peptides

A61K 39/21 (2006.01) Medicinal preparations containing antigens or antibodies - Retroviridae, e.g. equine infectious anemia virus

C07K 14/16 (2006.01) Peptides having more than 20 amino acids

C12N 15/49 (2006.01) Mutation or genetic engineering

Event Publications

1 March 2007 PCT application entered the National Phase

  PCT publication WO2006/013106 Priority application(s): WO2006/013106

24 May 2012 Application Accepted

  Published as AU-B-2005268856

20 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005268857-IL-17 antagonistic antibodies

2005268852-Sealing device with a hollow profile extrudate for sealing a joint between two structural bodies